Skip to content

Cureus

ISSN 2168-8184

214 papers in the library · 629 citations · publishing 2013-2026

Papers

Sort Most recent Most cited

Timely Management of Simultaneous Bilateral Spontaneous Pneumothorax: A Near-Death Experience.

Cureus February 1, 2023 Shilpa A Gaidhane, Nitish Batra, Apoorva Nirmal et al.

Simultaneous bilateral spontaneous pneumothorax is a situation that rarely occurs. The patient can have various presentations, from dyspnoea and chest pain to significant respiratory failure. Although it causes lung collapse in nearly two thirds of cases, early diagnosis and treatment are of the utmost importance. Here, we present the case of an 18-year-old boy who presented with complaints of...

DOI: 10.7759/cureus.34684 (opens in new tab) Full text (opens in new tab) Case report Life threatening presentation Sub pleural bull Tuberculosis

Two Cases of Dextromethorphan Overdose Reversed by Naloxone

Cureus February 1, 2023 Dhruva Kumar, V. Shinde, Sweta Khuraijam et al.

We present two rare cases highlighting the rare toxicological manifestation of dextromethorphan (DXM). The DXM toxicity profile is predominantly hallucinations, agitation, irritability with seizures, and coma in severe overdose. The cases that follow are unique in the sense that both patients had features of opioid toxidrome, rarely manifested in DXM abuse. A young male and female in their...

Subacute Combined Degeneration of the Spinal Cord Secondary to Nitrous Oxide Abuse

Cureus February 1, 2023 Aamir Khan, A. Zafar, H. Hamid et al.

Here, we report a case of subacute combined degeneration (SCD) of the spinal cord in the setting of nitrous oxide poisoning seen at the Medical Ward, Queen Elizabeth Hospital Birmingham Our patient was a 28-year-old lady who presented with impaired sensations in the lower limbs and difficulty walking for approximately one and a half months. Her clinical symptoms did not match common...

Co-Occurring Subacute Combined Degeneration and Guillain-Barré Syndrome Resulting From Nitrous Oxide Abuse: A Case Report.

Cureus December 1, 2022 Kristen Strom, Ateaya Lima, Vahideh Tabarzadi

Growing in prevalence as a recreational drug of abuse across a broad scope of people, nitrous oxide (N2O) has proven to be a public health concern. Side effects of its abuse have a great degree of variation among people ranging from neurologic, psychiatric, and medical symptoms. We present a rare case of a 23-year-old female with a history of N2O abuse, who presented with symptoms of both...

Psychotic Cannabis Withdrawal: A Clinical Case

Cureus November 13, 2022 Berta Rita Martins Ramos, Ana Filipa Santos Martins, Eva Sofia Lima Osório 5 citations

Cannabis use has been associated with several psychiatric comorbidities and there appears to be a dose-response relationship between the intensity and duration of its use and the risk of psychosis. More commonly, acute episodes of cannabis induced-psychosis manifest immediately following exposure, are precipitated after the use of large amounts of cannabis, resolve with abstinence, and are of...

Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.

Cureus November 1, 2022 Ricardo Irizarry, Amelia Winczura, Omar Dimassi et al. 26 citations

Psilocybin is an emerging potential therapy for the treatment of psychiatric illnesses. Microdosing has been shown to result in an overall improvement in patients with anxiety, depression, obsessive-compulsive disorder, post-traumatic stress disorder, and substance abuse. This meta-analysis explores and compiles prior research to make further inferences regarding psilocybin and its use for the...

The Efficacy of Psychedelic-Assisted Therapy in Managing Post-traumatic Stress Disorder (PTSD): A New Frontier?

Cureus October 31, 2022 Arafath Mohamed, Shehla Touheed, Muzammil Ahmed et al. 11 citations

Post-traumatic stress disorder (PTSD) is a significant public health concern for which existing therapies are only marginally effective. Indisputably, the primary line of treatment for PTSD is psychotherapy, according to current treatment guidelines. However, PTSD continues to be a chronic condition even after psychotherapy, with high psychiatric and medical illness rates. There is a dire need...

Potential Therapeutic Effects of Psilocybin: A Systematic Review.

Cureus October 1, 2022 Dev B Goel, Sarju Zilate 24 citations

Psilocybin is a plant alkaloid that is derived from precursors of tryptamine and is present in many different types of mushrooms. It has been utilized by indigenous peoples of Central and South America for centuries in a ceremonial setting to promote spiritual experiences. Indigenous societies have long employed psilocybin and other 5-HT 2A agonist classic psychedelics in their rites. They were...

A Case of Ecstasy-Induced Acute Hepatic Injury.

Cureus October 2022 Nava R Sharma, Bharosa Sharma, Saral Lamichhane et al.

The recreational use of a drug such as 3,4-methylenedioxymethamphetamine (MDMA), also known as "ecstasy," may be associated with significant side effects. Although liver failure with ecstasy is rare, the use of the drug should be investigated in all patients with severe hepatitis of unknown origin. Early diagnosis and intervention can prevent patients from ending up in liver transplantation....

The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.

Cureus September 1, 2022 Joshua S Kurtz, Neal A Patel, Julian L Gendreau et al. 35 citations

Although early therapeutic research on psychedelics dates back to the 1940s, this field of investigation was met with many cultural and legal challenges in the 1970s. Over the past two decades, clinical trials using psychedelics have resumed. Therefore, the goal of this study was to (1) better characterize the recent uptrend in psychedelics in clinical trials and (2) identify areas where...

Effect of Practicing Meditation, Pranayama, and Yoga on the Mental Health of Female Undergraduate Medical Students: An Interventional Study

Cureus September 1, 2022 M. Lata, Himel Mondal, Manish Kumar et al.

Background Medical education is a rigorous formal education with a vast syllabus. Burnout and stresses are common among medical students and more prominent in females. Female medical students suffer from a higher level of stress than male medical students. For the improvement of physical and mental health, meditation, pranayama, and yoga are some of the ancient techniques. Meditation is a...

A Pragmatic Comparison Between Aerobic Exercise and Suryanamaskar in Stress Management in Medical Professionals: A Quasi-experimental Study.

Cureus September 2022 Sharvari J Joshi, Sabih N Khan, Jeet S Kantharia et al.

Background Stress is an episodic process in an individual's life that depends upon the circumstances that elicit this process, later jeopardizing an individual's mental balance and leading to depression and anxiety. Yoga is a traditional component of physical activity that contains three main domains, namely, maintaining the correct posture (asanas), control over one's breath (pranayama) and...

DOI: 10.7759/cureus.29414 (opens in new tab) Full text (opens in new tab) Aerobic exercise Fitt Medical professionals Quasi-experimental study +3

Psychedelics: Their Limited Understanding and Future in the Treatment of Chronic Pain

Cureus August 25, 2022 Vedant N Hedau, Ashish P Anjankar 5 citations

Psychedelics are hallucinogenic drugs that alter the state of consciousness substantially. They bring about psychological, auditory, and visual changes. The psychedelics act on the brain, implying that they have a powerful psychological impact. One of the main factors contributing to disability worldwide is pain. The majority of people deal with pain on a daily basis. Living with chronic pain...

Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review

Cureus June 28, 2022 Ann M. Inouye, Aaron Wolfgang 5 citations

The Food and Drug Administration (FDA) granted breakthrough therapy status to 3,4-methyl​enedioxy​methamphetamine-assisted therapy (MDMA-AT) in 2017 due to preliminary evidence supporting its efficacy and safety in treating post-traumatic stress disorder (PTSD). A series of six phase-II clinical trials studying MDMA-AT for treatment-resistant PTSD found that 54% of MDMA-AT full-dose...

A Study on the Willingness to Use Meditation for Maintaining Psychological Well-Being During the COVID-19 Pandemic.

Cureus June 2022 Divya Jain, Vivek Verma, Neha Parashar et al.

Background and objective Several studies have indicated an escalation in the stress and anxiety levels among all sections of the population at large during the ongoing coronavirus disease 2019 (COVID-19) pandemic. In this challenging environment, meditation or yoga can help in maintaining the quality of life. This pilot study aimed to assess the willingness to practice meditation as a tool to...

DOI: 10.7759/cureus.25950 (opens in new tab) Full text (opens in new tab) Coronavirus anxiety scale Covid 19 Generalized anxiety scale Logistic regression +2

Unraveling the Mysteries of Mental Illness With Psilocybin

Cureus May 27, 2022 Robert Sotille, Herpreet Singh, Anne Weisman et al. 2 citations

Current medications have not been effective in reducing the prevalence of mental illness worldwide. The prevalence of illnesses such as treatment-resistant depression has increased despite the widespread use of a broad set of psychopharmaceuticals. Transcranial magnetic stimulation and ketamine therapy are making great strides in improving treatment-resistant depression outcomes but they have...

Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon

Cureus May 23, 2022 Kawther N Elsouri, Sahand Kalhori, Diego Colunge et al. 15 citations

Post-traumatic stress disorder (PTSD) is an anxiety disorder that often presents after exposure to a traumatic, life-threatening event. Experiencing a traumatic event is not rare, with inciting incidents ranging from being burglarized to politically motivated genocide. While traditional psychopharmacology and psychotherapy are the mainstays of the treatment of PTSD currently, psychoactive drugs...

“Esketamine” in Borderline Personality Disorder: A Look Beyond Suicidality

Cureus April 30, 2022 Neethu K Nandan, Puneet K Soni, Ajay K. Parsaik et al. 11 citations

Borderline personality disorder (BPD) is an extremely disabling condition that affects almost every dimension of a patient's life. The S-enantiomer of ketamine (esketamine) was approved by the Food and Drug Administration (FDA) in 2019 in conjunction with an oral antidepressant for the management of treatment-resistant depression (TRD) in adults. Our patient is a 27-year-old female with a...

Syndrome of Inappropriate Antidiuretic Hormone Secretion Following Ayahuasca Use in a Satanic Ritual: A Case Report

Cureus April 20, 2022 Maryam Bayat Mokhtari, Moein Bayat Mokhtari, Blanca Z Rodriguez et al. 3 citations

Ayahuasca is a psychedelic blend originating from South America that has been used for hundreds of years by local tribes in ritualistic ceremonies. For the last few decades, its usage has expanded to North America in various mindfulness retreats that can benefit from its hallucinogenic properties. In this case report, our patient had attended a satanic ritual where he had consumed copious...

The Therapeutic Effects of Ketamine in Mental Health Disorders: A Narrative Review

Cureus March 30, 2022 Carolina Sepulveda Ramos, Matthew P. Thornburg, Kelly A Long et al. 9 citations

Ketamine, a non-competitive N-methyl-d-aspartate receptor antagonist, is commonly used as an anesthetic and analgesic but has recently shown promising research in treating certain psychiatric conditions such as depression, post-traumatic stress disorder (PTSD), suicidal ideation, and substance use disorder. Due to its euphoric, dissociative, and hallucinogenic properties, ketamine has been...

A Retrospective Analysis of Three Focused Attention Meditation Techniques: Mantra, Breath, and External-Point Meditation.

Cureus March 28, 2022 Kirti Sharma, A Gabriella Wernicke, Husneara Rahman et al.

Objective The goal of this study is to compare the effectiveness of three different meditation techniques (two internal focus techniques and one external focus technique) using a low-cost portable electroencephalography (EEG) device, namely, MUSE, for an objective comparison. Methods This is an IRB-approved retrospective study. All participants in the study were healthy adults. Each study...

Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review

Cureus February 5, 2022 Shawn Ziff, Benjamin Stern, Gregory D. Lewis et al. 32 citations

Psilocybin-containing mushrooms have been consumed by various cultures in many different parts of the world for thousands of years. Psilocybin, a classic psychedelic, contains unique psychoactive properties and has been incorporated into religious ceremonies and investigated for its medicinal value. In the mid-20th century, psilocybin, along with most other classic psychedelics (5HT-2A...

Mindfulness and Wellbeing Among College Students During the COVID-19 Pandemic: A Qualitative Analysis of Emergent Themes and Concerns.

Cureus December 27, 2021 Julianna A Rava, Emily Hotez

Emerging adulthood (ages of 18-30 years) is a critical developmental period characterized by mental health challenges, particularly for college students who experience distinct mental health issues. Mindfulness-based approaches have been associated with mental health benefits. This study aimed to assess the mental health and wellbeing of college students with qualitative data obtained via their...

Cannabis-Induced Malignant Catatonia: A Medical Emergency and Review of Prior Case Series

Cureus August 27, 2021 Batool Sheikh, Tinu Hirachan, Kunal K. Gandhi et al. 5 citations

Few case reports of catatonia associated with cannabis use are reported. Here, we describe a case of a 35-year-old African American male who developed malignant catatonia following heavy cannabis use. The patient was brought to the emergency department (ED) for altered mental status, hypertension, and erratic behavior. Before his ED presentation, he was smoking cannabis in heavy amounts,...

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review

Cureus August 21, 2021 Alisha Sapkota, Hajra Khurshid, Israa A Qureshi et al. 44 citations

Intranasal form of esketamine, the S-enantiomer of racemic ketamine, was approved by the US FDA in 2019 for treatment-resistant depression (TRD) in adults. Since intranasal esketamine is a newly approved drug with a novel mechanism of action, much still remains unknown in regard to its use in TRD. The objective of this study is to systematically review the latest existing evidence on intranasal...